Cardiac magnetic resonance imaging identification of myocardial fibrosis: The need for standardization and therapies

Journal of the American College of Cardiology

Volumn 56, Issue 4, 2010, Pages 288-289

  Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

aortic valve disease; histopathology; magnetic resonance imaging; myocardial fibrosis; prognosis

Indexed keywords

ANTIFIBROTIC AGENT; GADOLINIUM CHELATE;

AORTA VALVE DISEASE; CARDIAC MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE MARKER; DRUG INDICATION; EDITORIAL; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ENHANCEMENT; KIDNEY FAILURE; MORTALITY; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VALVULAR HEART DISEASE;

AORTIC VALVE STENOSIS; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MYOCARDIUM;

EID: 77955639437     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.063     Document Type: Editorial

References (21)

1. M.T. McNamara, C.B. Higgins, and R.L. Ehman, et al. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA Radiology 153 1984 157 163
2. O.P. Simonetti, R.J. Kim, and D.S. Fieno, et al. An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 2001 215 223
3. R.J. Kim, D.S. Fieno, and T.B. Parrish, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age and contractile function Circulation 100 1999 1992 2002
4. R.J. Kim, E. Wu, and A. Rafael, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
5. J.A. McCrohon, J.C. Moon, and S.K. Prasad, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
6. A. Rudolph, H. Abdel-Aty, and S. Bohl, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy: relation to remodeling J Am Coll Cardiol 53 2009 284 291
7. J.P. Smedema, G. Snoep, and M.P. van Kroonenburgh, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
8. A.M. Maceira, J. Joshi, and S.K. Prasad, et al. Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
9. B.J. Schietinger, G.M. Brammer, and H. Wang, et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients J Am Coll Cardiol Img 1 2008 450 456
10. R.Y. Kwong, A.K. Chan, and K.A. Brown, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
11. R.Y. Kwong, H. Sattar, and H. Wu, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction Circulation 118 2008 1011 1020
12. H.W. Kim, I. Klem, and D.J. Shah, et al. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease PLoS Med 6 2009 e1000057
13. A.T. Yan, A.J. Shayne, and K.A. Brown, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality Circulation 114 2006 32 39
14. A. Schmidt, C.F. Azevedo, and A. Cheng, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction Circulation 115 2007 2006 2014
15. S.D. Roes, C.J. Borleffs, and R.J. van der Geest, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator Circ Cardiovasc Imaging 2 2009 183 190
16. S. Nazarian, D.A. Bluemke, and A.C. Lardo, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
17. R.G. Assomull, S.K. Prasad, and J. Lyne, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
18. A.S. Adabag, B.J. Maron, and E. Appelbaum, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
19. C.F. Azevedo, M. Nigri, and M.L. Higuchi, et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J Am Coll Cardiol 56 2010 278 287
20. F. Weidemann, S. Herrmann, and S. Stork, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis Circulation 120 2009 577 584
21. L. Iles, H. Pfluger, and A. Phrommintikul, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580